Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Caris Life Sciences, Qlucore, Biocartis, More

Caris Life Sciences Human Leukocyte Antigen Genotype Reporting

Caris Life Sciences has launched Human Leukocyte Antigen (HLA) Genotype reporting. The product strengthens physicians' ability to provide more individualized treatment decisions for their patients, and the results may also provide additional insight for patient enrollment into clinical trials and patients' response to immunotherapy, the company said.

Effective immediately, HLA Genotype results will be reported as a genomic signature, along with tumor mutational burden, microsatellite instability, and loss of heterozygosity as standard reporting elements for patients profiled by Caris.


Qlucore Omics Explorer Version 3.7

Qlucore has introduced version 3.7 of its Qlucore Omics Explorer, which the company dubbed an "extensive upgrade" to its flagship bioinformatics product. The new release adds support for ChIP-seq and ATAC-seq analysis. It also features new visualizaton functions and a redesigned statistical framework for the built-in genome browser, plus a redesigned biomarker workbench that has been optimized for biomarker discovery and drug development.


Biocartis Idylla GeneFusion Assay 

Biocartis has launched its Idylla GeneFusion Assay. The firm said the research-use-only test analyzes a wide range of biomarkers covering all gene fusions considered to be relevant in cancer research, including ALK, ROS1, RET, NTRK1/2/3 fusions, and MET exon 14 skipping mutations. Biocartis' test, which produces results within three hours, is the first formalin-fixed, paraffin-embedded RNA-based assay on Biocartis' Idylla platform.


For more new products and services, please visit the New Products page on our website.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.